Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Comparison

cjc 1295 vs ipamorelin: Topic comparisons

Approved comparison material connected to this topic.

51 total records
Side-by-side reading

Comparison records

Source comparisons are presented without a generated winner.

Comparison

CJC-1295 vs Sermorelin

Both are GHRH analogs targeting the same receptor, but they differ meaningfully in pharmacokinetics. Sermorelin is essentially the unmodified GHRH(1-29) fragment with a half-life of approximately 10 to 20 minu…

Read comparison →
Comparison

CJC-1295 vs Tesamorelin

Tesamorelin is the only GHRH analog with current FDA approval (granted in 2010 for HIV-associated lipodystrophy). It uses an N-terminal trans-3-hexenoic acid modification for DPP-4 resistance, giving it a half…

Read comparison →
Comparison

Quick Comparison

Type: CJC-1295 is a GHRH analog; Ipamorelin is a growth hormone secretagogue (GHRP). Mechanism: CJC-1295 activates GHRH receptors on pituitary somatotrophs; Ipamorelin activates ghrelin receptors (GHS-R1a) on …

Read comparison →
Comparison

A Head-to-Head Comparison

To make the differences as clear as possible, our team put together a straightforward comparison table. Sometimes seeing the data side-by-side is what really makes it click. Peptide Class GHRH Analog (Growth H…

Read comparison →
Comparison

Side-by-Side Comparison Table

Let’s compare Sermorelin, CJC-1295 (with/without DAC), and Ipamorelin across key factors: Feature Sermorelin (GHRH 1-29) CJC-1295 (No DAC) Mod GRF 1-29 CJC-1295 DAC Long-acting Ipamorelin (GHRP) Mechanism of A…

Read comparison →